Cargando…

Development of an accelerated cellular model for early changes in Alzheimer’s disease

Alzheimer’s Disease (AD) is a leading cause of dementia characterized by amyloid plaques and neurofibrillary tangles, and its pathogenesis remains unclear. Current cellular models for AD often require several months to exhibit phenotypic features due to the lack of an aging environment in vitro. Lam...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xue, Huijing, Gate, Sylvester, Gentry, Emma, Losert, Wolfgang, Cao, Kan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603068/ https://www.ncbi.nlm.nih.gov/pubmed/37884611 http://dx.doi.org/10.1038/s41598-023-45826-5

Ejemplares similares

From Cellular Characteristics to Disease Diagnosis: Uncovering Phenotypes with Supercells
por: Candia, Julián, et al.
Publicado: (2013)

Magnetic Resonance Imaging to Detect Early Molecular and Cellular Changes in Alzheimer's Disease
por: Knight, Michael J., et al.
Publicado: (2016)

Cellular Contact Guidance through Dynamic Sensing of Nanotopography
por: Driscoll, Meghan K., et al.
Publicado: (2014)

Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer’s disease
por: Pooler, Amy M, et al.
Publicado: (2015)

Accelerated Aging Characterizes the Early Stage of Alzheimer’s Disease
por: Leparulo, Alessandro, et al.
Publicado: (2022)

Macrophages in Alzheimer’s disease: the blood-borne identity
por: Gate, David, et al.
Publicado: (2010)

A Federated Learning Model Based on Hardware Acceleration for the Early Detection of Alzheimer’s Disease
por: Khalil, Kasem, et al.
Publicado: (2023)

Early Cellular, Molecular, Morphological and Behavioral Changes in the Humanized Amyloid-Beta-Knock-In Mouse Model of Late-Onset Alzheimer’s Disease
por: Kshirsagar, Sudhir, et al.
Publicado: (2022)

Effects of Urolithin A on Mitochondrial Parameters in a Cellular Model of Early Alzheimer Disease
por: Esselun, Carsten, et al.
Publicado: (2021)

The Potentials of Methylene Blue as an Anti-Aging Drug
por: Xue, Huijing, et al.
Publicado: (2021)

Impaired LEF1 Activation Accelerates iPSC-Derived Keratinocytes Differentiation in Hutchinson-Gilford Progeria Syndrome
por: Mao, Xiaojing, et al.
Publicado: (2022)

Amyloid Structural Changes Studied by Infrared Microspectroscopy in Bigenic Cellular Models of Alzheimer’s Disease
por: Paulus, Agnes, et al.
Publicado: (2021)

Actin Dynamics as a Multiscale Integrator of Cellular Guidance Cues
por: Bull, Abby L., et al.
Publicado: (2022)

Automated image analysis of nuclear shape: What can we learn from a prematurely aged cell?
por: Driscoll, Meghan K., et al.
Publicado: (2012)

Alzheimer’s Model Develops Early ADHD Syndrome
por: Zhang, Qiang, et al.
Publicado: (2015)

Economic analysis of opportunities to accelerate Alzheimer’s disease research and development
por: Scott, Troy J, et al.
Publicado: (2014)

Early Changes in Hippocampal Neurogenesis in Transgenic Mouse Models for Alzheimer’s Disease
por: Unger, M. S., et al.
Publicado: (2016)

Using Optogenetics to Model Cellular Effects of Alzheimer’s Disease
por: Tiwari, Prabhat, et al.
Publicado: (2023)

HSV-1 cellular model reveals links between aggresome formation and early step of Alzheimer’s disease
por: Albaret, Marie Alexandra, et al.
Publicado: (2023)

Modeling and Measuring Signal Relay in Noisy Directed Migration of Cell Groups
por: Guven, Can, et al.
Publicado: (2013)

DNA Demethylation Upregulated Nrf2 Expression in Alzheimer’s Disease Cellular Model
por: Cao, Huimin, et al.
Publicado: (2016)

Cellular basis of Alzheimer’s disease
por: Bali, Jitin, et al.
Publicado: (2010)

Cortical waves mediate the cellular response to electric fields
por: Yang, Qixin, et al.
Publicado: (2022)

Quantification of white matter cellularity and damage in preclinical and early symptomatic Alzheimer's disease
por: Wang, Qing, et al.
Publicado: (2019)

Digital technologies for cognitive assessment to accelerate drug development in Alzheimer's disease
por: Leurent, C, et al.
Publicado: (2015)

Accelerating drug development for Alzheimer's disease through the use of data standards
por: Neville, Jon, et al.
Publicado: (2017)

Targeted Lipidomics of Mitochondria in a Cellular Alzheimer’s Disease Model
por: Kurokin, Irina, et al.
Publicado: (2021)

The cellular model for Alzheimer's disease research: PC12 cells
por: Xie, Danni, et al.
Publicado: (2023)

Speaking in Alzheimer’s Disease, is That an Early Sign? Importance of Changes in Language Abilities in Alzheimer’s Disease
por: Szatloczki, Greta, et al.
Publicado: (2015)

BACE1 in the retina: a sensitive biomarker for monitoring early pathological changes in Alzheimer's disease
por: Li, Lan, et al.
Publicado: (2016)

Establishment and evaluation of transgenic models of Alzheimer's disease with senescence accelerated background
por: Zhao, Wenjuan, et al.
Publicado: (2012)

Early Cortical Changes in Gamma Oscillations in Alzheimer’s Disease
por: Klein, Alexandra S., et al.
Publicado: (2016)

Detecting early changes in Alzheimer’s disease with graph theory
por: Pereira, Joana B
Publicado: (2020)

Protocol for electrical modulation of ERK signaling dynamics in cell lines
por: Zhu, Kan, et al.
Publicado: (2022)

Reduced presynaptic vesicle stores mediate cellular and network plasticity defects in an early-stage mouse model of Alzheimer’s disease
por: Chakroborty, Shreaya, et al.
Publicado: (2019)

Walnut Oil Reduces Aβ Levels and Increases Neurite Length in a Cellular Model of Early Alzheimer Disease
por: Esselun, Carsten, et al.
Publicado: (2022)

Aging, Cellular Senescence, and Alzheimer’s Disease
por: Liu, Rui-Ming
Publicado: (2022)

A nonhuman primate model of early Alzheimer’s disease pathologic change: Implications for disease pathogenesis
por: Latimer, Caitlin S., et al.
Publicado: (2018)

Recent Development in the Understanding of Molecular and Cellular Mechanisms Underlying the Etiopathogenesis of Alzheimer’s Disease
por: Afsar, Atefeh, et al.
Publicado: (2023)

Deciphering cellular transcriptional alterations in Alzheimer’s disease brains
por: Wang, Xue, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9ifnlkf7ogvn7uieeclhg3q98c